EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

How CYP2D6 Polymorphism Modulates the Community-Wide Risk of Plasmodium vivax Infection: A Panel Study in Amazonian Brazil

Maria Carolina Silva de Barros Puça iD, Isabela Marques Naziazeno, Viviane Cristina Fernandes Dos Santos iD, Priscila Thihara Rodrigues, Priscila Rodrigues Calil iD, Winni Alves Ladeia iD, José Pedro Gil iD, Marcelo Urbano Ferreira, Tais Nobrega De Sousa iD

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Maria Carolina Silva de Barros Puça und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology and Malaria Immunology Research Group, Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2D6, Malaria, Vivax, Polymorphism, Genetic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Portugal, Fundação de Amparo à Pesquisa do Estado de São Paulo, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The CYP2D6 enzyme plays a critical role in the metabolism of primaquine, the most widely used drug for the radical cure of Plasmodium vivax malaria. Impaired CYP2D6 activity has been associated with an increased risk of relapse. However, the overall impact of CYP2D6 on infection dynamics is still not fully understood. We hypothesized that individuals with impaired CYP2D6 activity develop partial immunity more rapidly due to the ineffective clearance of hypnozoites.

Methods

To test this hypothesis, we conducted a community-based study involving ∼1300 individuals genotyped for CYP2D6 and assessed repeatedly for P. vivax using molecular diagnosis. This approach allowed us to detect and monitor submicroscopic and asymptomatic infections over a 4-year follow-up period.

Results

In our cohort, children with impaired CYP2D6 activity exhibited a higher frequency of P. vivax infections compared with those with normal enzyme activity. This pattern changed during the second decade of life, as the prevalence of P. vivax infection increased in adolescents with normal enzyme activity (P = .0008, Generalized additive mixed model). Consistent with this, parasite densities were lower in adults with impaired CYP2D6 activity compared with younger individuals with normal enzyme activity (P = .0383, Linear mixed model).

Conclusions

These findings underscore the potential role of CYP2D6 in shaping infection dynamics and malaria immunity in endemic areas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP2D6Malaria, VivaxPolymorphism, GeneticHumansBrazilAdolescentAdultFemaleMaleChildPlasmodium vivaxYoung AdultChild, PreschoolMiddle AgedInfantGenotypeCohort Studies

Stichwörter der Autor:innen

Plasmodium vivaxCYP2D6malariaprimaquinerisk of infection

Substanzen

Cytochrome P-450 CYP2D6

Autor:innen und Institutionen

  • Molecular Biology and Malaria Immunology Research Group, Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.
  • Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden.
  • Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • Clinical Tropical Medicine, Global Health and Tropical Medicine (GHTM), Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon, Lisbon, Portugal.
  • Global Health and Tropical Medicine (GHTM) Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon, Lisbon, Portugal.

ORCID-Profile: Maria Carolina Silva de Barros Puça, Viviane Cristina Fernandes Dos Santos, Priscila Rodrigues Calil, Winni Alves Ladeia, José Pedro Gil, Tais Nobrega De Sousa

Förderung

  • Fundação para a Ciência e Tecnologia, Portugal
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • NIH HHS
  • NIAID NIH HHS
  • Swedish Research Council Grant
  • Programa PrInt-Fiocruz-CAPES
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • National Institutes of Health

Zitieren

APA

Puça, M. C. S. B., Naziazeno, I. M., Santos, V. C. F. D., Rodrigues, P. T., Calil, P. R., Ladeia, W. A., Gil, J. P., Ferreira, M. U., & Nobrega De Sousa, T. (2025). How CYP2D6 Polymorphism Modulates the Community-Wide Risk of Plasmodium vivax Infection: A Panel Study in Amazonian Brazil. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf412

Vancouver

Puça MCSB, Naziazeno IM, Santos VCFD, Rodrigues PT, Calil PR, Ladeia WA, et al. How CYP2D6 Polymorphism Modulates the Community-Wide Risk of Plasmodium vivax Infection: A Panel Study in Amazonian Brazil. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf412

BibTeX
@article{Pua2025,
  author = {Puça, Maria Carolina Silva de Barros and Naziazeno, Isabela Marques and Santos, Viviane Cristina Fernandes Dos and Rodrigues, Priscila Thihara and Calil, Priscila Rodrigues and Ladeia, Winni Alves and Gil, José Pedro and Ferreira, Marcelo Urbano and Nobrega De Sousa, Tais},
  title = {How CYP2D6 Polymorphism Modulates the Community-Wide Risk of Plasmodium vivax Infection: A Panel Study in Amazonian Brazil},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf412}
}
Kostenlos starten →